Several predictors of fgSRL resistance have been described previously and include male sex, younger age, initial GH and IGF-1 levels, high tumor volume, tumor hyperintensity on T2-weighted MRI and the expression of SSTR subtypes, among others (43). This evidence concerns the gene GH1 and neoplasm.